Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Cortical thinning is associated with disease stages and dementia in Parkinson's disease.

Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, Tolosa E, Martí MJ.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):875-81. doi: 10.1136/jnnp-2012-304126. Epub 2013 Mar 5.

2.

MRI and cognitive impairment in Parkinson's disease.

Ibarretxe-Bilbao N, Tolosa E, Junque C, Marti MJ.

Mov Disord. 2009;24 Suppl 2:S748-53. doi: 10.1002/mds.22670. Review.

PMID:
19877242
3.

Cognitive impairment and dementia in Parkinson's disease.

Pagonabarraga J, Kulisevsky J.

Neurobiol Dis. 2012 Jun;46(3):590-6. doi: 10.1016/j.nbd.2012.03.029. Epub 2012 Mar 30. Review.

PMID:
22484304
4.

Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.

Kulisevsky J, Pagonabarraga J.

Mov Disord. 2009 Jun 15;24(8):1103-10. doi: 10.1002/mds.22506. Review.

PMID:
19353727
5.

Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease?

Duncan GW, Firbank MJ, O'Brien JT, Burn DJ.

Mov Disord. 2013 Apr;28(4):425-38. doi: 10.1002/mds.25352. Epub 2013 Feb 28. Review.

PMID:
23450518
6.

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA.

Brain. 2007 Jul;130(Pt 7):1787-98. Epub 2007 May 29. Review.

PMID:
17535834
7.

Cognitive dysfunction and dementia in Parkinson's disease.

Bosboom JL, Stoffers D, Wolters ECh.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1303-15. Epub 2004 Jun 30. Review.

PMID:
15480840
8.

Cognitive impairment in Parkinson's disease.

Cosgrove J, Alty JE, Jamieson S.

Postgrad Med J. 2015 Apr;91(1074):212-20. doi: 10.1136/postgradmedj-2015-133247. Epub 2015 Mar 26. Review.

PMID:
25814509
9.

Neuroimaging and cognition in Parkinson's disease dementia.

Silbert LC, Kaye J.

Brain Pathol. 2010 May;20(3):646-53. doi: 10.1111/j.1750-3639.2009.00368.x. Review.

10.

Olfactory dysfunction and dementia in Parkinson's disease.

Takeda A, Baba T, Kikuchi A, Hasegawa T, Sugeno N, Konno M, Miura E, Mori E.

J Parkinsons Dis. 2014;4(2):181-7. doi: 10.3233/JPD-130277. Review.

PMID:
24625830
11.

Functional brain imaging of cognitive dysfunction in Parkinson's disease.

Hirano S, Shinotoh H, Eidelberg D.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):963-9. doi: 10.1136/jnnp-2011-301818. Epub 2012 Jul 17. Review.

PMID:
22807560
12.

Dementia associated with Parkinson's disease.

Emre M.

Lancet Neurol. 2003 Apr;2(4):229-37. Review.

PMID:
12849211
13.

Profile of cognitive impairment in Parkinson's disease.

Watson GS, Leverenz JB.

Brain Pathol. 2010 May;20(3):640-5. doi: 10.1111/j.1750-3639.2010.00373.x. Review.

14.

A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.

Calabresi P, Picconi B, Parnetti L, Di Filippo M.

Lancet Neurol. 2006 Nov;5(11):974-83. Review.

PMID:
17052664
15.

Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions.

Zgaljardic DJ, Foldi NS, Borod JC.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1287-301. Epub 2004 Jul 7. Review.

PMID:
15480839
16.

Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages.

Borghammer P, Chakravarty M, Jonsdottir KY, Sato N, Matsuda H, Ito K, Arahata Y, Kato T, Gjedde A.

Brain Struct Funct. 2010 May;214(4):303-17. doi: 10.1007/s00429-010-0246-0. Epub 2010 Apr 2. Review.

PMID:
20361208
17.

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease.

Kehagia AA, Barker RA, Robbins TW.

Lancet Neurol. 2010 Dec;9(12):1200-13. doi: 10.1016/S1474-4422(10)70212-X. Epub 2010 Sep 27. Review.

PMID:
20880750
18.

Cognitive and motor dysfunction in Parkinson's disease. Clinical, performance, and computed tomographic correlations.

Lichter DG, Corbett AJ, Fitzgibbon GM, Davidson OR, Hope JK, Goddard GV, Sharples KJ, Pollock M.

Arch Neurol. 1988 Aug;45(8):854-60. Review.

PMID:
3293555
19.

Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.

Narayanan NS, Rodnitzky RL, Uc EY.

Rev Neurosci. 2013;24(3):267-78. doi: 10.1515/revneuro-2013-0004. Review.

20.

On visual hallucinations and cortical networks: a trans-diagnostic review.

Carter R, Ffytche DH.

J Neurol. 2015 Jul;262(7):1780-90. doi: 10.1007/s00415-015-7687-6. Epub 2015 Mar 13. Review.

Supplemental Content

Support Center